B
Beyond Medical Technologies Inc
CNSX:DOCT
Beyond Medical Technologies Inc
CNSX:DOCT
Price:
0.19
CAD
Market Closed
Market Cap:
CA$6.2m
Balance Sheet
Balance Sheet Decomposition
Beyond Medical Technologies Inc
Beyond Medical Technologies Inc
Balance Sheet Decomposition is not available for
Beyond Medical Technologies Inc
Beyond Medical Technologies Inc
Balance Sheet
Beyond Medical Technologies Inc
Beyond Medical Technologies Inc
Currency: CAD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
3
|
5
|
3
|
3
|
1
|
1
|
1
|
0
|
0
|
|
| Cash |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
5
|
3
|
3
|
1
|
1
|
1
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
4
|
5
|
6
|
3
|
1
|
2
|
1
|
0
|
0
|
|
| PP&E Net |
1
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
4
+303%
|
6
+56%
|
9
+47%
|
4
-55%
|
2
-52%
|
2
+6%
|
1
-69%
|
0
-84%
|
0
-86%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-62%
|
0
-27%
|
0
+139%
|
0
+8%
|
0
+18%
|
0
+14%
|
0
-16%
|
0
+24%
|
1
+47%
|
|
| Equity | |||||||||||
| Common Stock |
17
|
21
|
12
|
18
|
18
|
21
|
24
|
24
|
24
|
24
|
|
| Retained Earnings |
16
|
18
|
6
|
10
|
15
|
19
|
22
|
23
|
24
|
24
|
|
| Total Equity |
0
N/A
|
4
+616%
|
6
+59%
|
8
+45%
|
4
-57%
|
1
-58%
|
2
+4%
|
0
-83%
|
0
N/A
|
1
-85%
|
|
| Total Liabilities & Equity |
1
N/A
|
4
+303%
|
6
+56%
|
9
+47%
|
4
-55%
|
2
-52%
|
2
+6%
|
1
-69%
|
0
-84%
|
0
-86%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
6
|
2
|
3
|
4
|
4
|
6
|
8
|
8
|
8
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
